Market Cap 3.74B
Revenue (ttm) 1.53B
Net Income (ttm) 312.44M
EPS (ttm) N/A
PE Ratio 9.65
Forward PE 10.79
Profit Margin 20.37%
Debt to Equity Ratio 0.49
Volume 842,500
Avg Vol 1,691,116
Day's Range N/A - N/A
Shares Out 67.99M
Stochastic %K 27%
Beta 0.15
Analysts Strong Sell
Price Target $95.54

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 978 671 8001
Fax: 978 671 8860
Address:
201 Burlington Road, South Building, Bedford, United States
RadioIsotope25
RadioIsotope25 Sep. 12 at 12:33 PM
$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH
0 · Reply
Live2ride
Live2ride Sep. 11 at 8:26 PM
$LNTH 20dma acting as nasty resistance.
0 · Reply
DKFutureInvest
DKFutureInvest Sep. 11 at 7:33 PM
$LNTH y’all think it’s due to all the shorts that the price action is so explosive?
1 · Reply
Live2ride
Live2ride Sep. 11 at 7:27 PM
$LNTH $55.20 area key. Let's break through it this time and reverse this down trend! I love the smell of cheap Oct calls.
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 1:30 AM
$RADX “We are pleased to make a strategic investment in RAD and partner with them to further expand our innovative pipeline,” said Brian Markison, Chief Executive Officer of Lantheus. “Radiopharmaceutical theranostics are changing the way cancer is diagnosed and treated, yet we still have more work to do and are inspired to further advance this field with these two preclinical oncology assets. $LNTH $ATNM $CSBR
3 · Reply
LoneBroker
LoneBroker Sep. 10 at 5:42 PM
$LNTH$52.19 🐻 • RSI 39 • ATR 4.2% • vol↑ Support & Resistance — UPDATED 10/09/2025 5 Days | Support: $51.20 – $52.00 | Resistance: $53.00 – $54.00 20 Days | Support: $50.00 – $52.00 | Resistance: $55.00 – $57.00 60 Days | Support: $47.00 – $50.00 | Resistance: $58.00 – $60.00 LNTH ($52.19) slid over 5% today, extending its downtrend after failing to hold above $55. Recent weakness puts focus on the $51$52 support band, with deeper risk toward $50 if pressure continues. Momentum remains bearish with RSI in the high 30s, while volatility has expanded. Bulls need a reclaim above $55 to ease selling pressure and shift bias back toward $57$60. 📌 RSI = momentum index (0–100). >50 = strength, <50 = weakness 📌 ATR% = daily volatility (higher = bigger swings) 📌 Legend: 🐂 bullish • 🐻 bearish • 😐 neutral • vol↑ rising volume • vol↓ easing volume ⏳ Valid until: 16:00 ET / 13:00 PT (Mon–Fri) ---
0 · Reply
DKFutureInvest
DKFutureInvest Sep. 10 at 5:13 PM
$LNTH Honestly feels like this is one of the best opportunities in the market at the moment. But it might take a long time to realize..
1 · Reply
Live2ride
Live2ride Sep. 10 at 4:39 PM
$LNTH So much for breaking through the 20dma. Just a head fake. Feels like more pain before any gain. Feels like a typical MM game to take shares in low 50's / high 40's before any significant run. Hope that level holds.
0 · Reply
TPTradingCo
TPTradingCo Sep. 10 at 3:24 PM
$LNTH anything in their pipeline for men who suffer greatly from looking at this ticker?
0 · Reply
Starbeme
Starbeme Sep. 10 at 2:53 PM
$LNTH low 40s on the table
0 · Reply
Latest News on LNTH
Lantheus Holdings: Reassessing The Buy Thesis

Aug 6, 2025, 10:09 AM EDT - 5 weeks ago

Lantheus Holdings: Reassessing The Buy Thesis


Lantheus Holdings: Forget The Short Term Noise

Jul 21, 2025, 8:57 AM EDT - 7 weeks ago

Lantheus Holdings: Forget The Short Term Noise


Why Is Lantheus Stock Trading Lower On Wednesday?

Jul 16, 2025, 2:45 PM EDT - 2 months ago

Why Is Lantheus Stock Trading Lower On Wednesday?


Lantheus Seems Worth The (Very Real) Risks

Jul 1, 2025, 7:28 AM EDT - 2 months ago

Lantheus Seems Worth The (Very Real) Risks


Lantheus Holdings, Inc. (LNTH) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:23 AM EDT - 4 months ago

Lantheus Holdings, Inc. (LNTH) Q1 2025 Earnings Call Transcript


Lantheus Announces Sale of SPECT Business to SHINE Technologies

May 6, 2025, 4:01 PM EDT - 4 months ago

Lantheus Announces Sale of SPECT Business to SHINE Technologies


Lantheus Completes Acquisition of Evergreen Theragnostics

Apr 1, 2025, 9:00 AM EDT - 5 months ago

Lantheus Completes Acquisition of Evergreen Theragnostics


Lantheus Holdings, Inc. (LNTH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:49 AM EST - 7 months ago

Lantheus Holdings, Inc. (LNTH) Q4 2024 Earnings Call Transcript


Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D.

Jan 30, 2025, 8:30 AM EST - 8 months ago

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D.


Lantheus Holdings: Powerhouse Potential In 2025

Jan 1, 2025, 7:43 PM EST - 9 months ago

Lantheus Holdings: Powerhouse Potential In 2025


Lantheus Holdings: A Growing Business With Dominant Market Share

Dec 12, 2024, 2:01 PM EST - 9 months ago

Lantheus Holdings: A Growing Business With Dominant Market Share


Lantheus Announces Share Repurchase Program

Nov 20, 2024, 1:00 AM EST - 10 months ago

Lantheus Announces Share Repurchase Program


Lantheus to Present at the Jefferies London Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 10 months ago

Lantheus to Present at the Jefferies London Healthcare Conference


Lantheus Holdings: Q3 Results Were Good But Market Overreacted

Nov 8, 2024, 10:06 AM EST - 11 months ago

Lantheus Holdings: Q3 Results Were Good But Market Overreacted


Lantheus Holdings, Inc. (LNTH) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 11:27 AM EST - 11 months ago

Lantheus Holdings, Inc. (LNTH) Q3 2024 Earnings Call Transcript


RadioIsotope25
RadioIsotope25 Sep. 12 at 12:33 PM
$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH
0 · Reply
Live2ride
Live2ride Sep. 11 at 8:26 PM
$LNTH 20dma acting as nasty resistance.
0 · Reply
DKFutureInvest
DKFutureInvest Sep. 11 at 7:33 PM
$LNTH y’all think it’s due to all the shorts that the price action is so explosive?
1 · Reply
Live2ride
Live2ride Sep. 11 at 7:27 PM
$LNTH $55.20 area key. Let's break through it this time and reverse this down trend! I love the smell of cheap Oct calls.
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 1:30 AM
$RADX “We are pleased to make a strategic investment in RAD and partner with them to further expand our innovative pipeline,” said Brian Markison, Chief Executive Officer of Lantheus. “Radiopharmaceutical theranostics are changing the way cancer is diagnosed and treated, yet we still have more work to do and are inspired to further advance this field with these two preclinical oncology assets. $LNTH $ATNM $CSBR
3 · Reply
LoneBroker
LoneBroker Sep. 10 at 5:42 PM
$LNTH$52.19 🐻 • RSI 39 • ATR 4.2% • vol↑ Support & Resistance — UPDATED 10/09/2025 5 Days | Support: $51.20 – $52.00 | Resistance: $53.00 – $54.00 20 Days | Support: $50.00 – $52.00 | Resistance: $55.00 – $57.00 60 Days | Support: $47.00 – $50.00 | Resistance: $58.00 – $60.00 LNTH ($52.19) slid over 5% today, extending its downtrend after failing to hold above $55. Recent weakness puts focus on the $51$52 support band, with deeper risk toward $50 if pressure continues. Momentum remains bearish with RSI in the high 30s, while volatility has expanded. Bulls need a reclaim above $55 to ease selling pressure and shift bias back toward $57$60. 📌 RSI = momentum index (0–100). >50 = strength, <50 = weakness 📌 ATR% = daily volatility (higher = bigger swings) 📌 Legend: 🐂 bullish • 🐻 bearish • 😐 neutral • vol↑ rising volume • vol↓ easing volume ⏳ Valid until: 16:00 ET / 13:00 PT (Mon–Fri) ---
0 · Reply
DKFutureInvest
DKFutureInvest Sep. 10 at 5:13 PM
$LNTH Honestly feels like this is one of the best opportunities in the market at the moment. But it might take a long time to realize..
1 · Reply
Live2ride
Live2ride Sep. 10 at 4:39 PM
$LNTH So much for breaking through the 20dma. Just a head fake. Feels like more pain before any gain. Feels like a typical MM game to take shares in low 50's / high 40's before any significant run. Hope that level holds.
0 · Reply
TPTradingCo
TPTradingCo Sep. 10 at 3:24 PM
$LNTH anything in their pipeline for men who suffer greatly from looking at this ticker?
0 · Reply
Starbeme
Starbeme Sep. 10 at 2:53 PM
$LNTH low 40s on the table
0 · Reply
TI7812
TI7812 Sep. 10 at 2:16 PM
$LNTH Not happy with the selling. Was expecting continued buying.
1 · Reply
Blizzzard
Blizzzard Sep. 10 at 2:15 PM
$LNTH ouch
0 · Reply
Longterminvestor919
Longterminvestor919 Sep. 10 at 3:31 AM
$LNTH the mechanics of this is simple. The company buying shares reduces outstanding share count thus increasing EPS as long as earning remained at least flat.
0 · Reply
Longterminvestor919
Longterminvestor919 Sep. 10 at 1:49 AM
$LNTH just listened to presentation. The CEO said the company has been actively buying shares and that if they need to go back to the board to get authorization for more money for buybacks then theyll do it. He said right now the stock price is dislocated and undervalued.
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 9 at 10:25 PM
$RADX Maybe they announce all the data around the webinar on the 24th… that’s not many trading days from now. Her2 - Massive Market Mets Imaging- 300,000 patient market (large they say it’s larger in USA than prostate- well prostate made the market for Telix and Lantheus both $3 billion plus companies. Pancreatic Imaging- more niche but potentially lucrative. If they fire on all cylinders this will be multiples higher and this float is tight. Hopefully the 80,000 share bid was a signal of good news to come at $5.36 Market cap of Radiopharm Theranostics is at least 5 times smaller than all their past two acquisitions averages. Heavy insider buying past 12-months and Lantheus just bought more at $11.70 in first quarter. Rayze Bio and Fusion were billion dollar Radiopharmaceutical acquisitions and I love this MD Anderson collaboration to produce 4 therapeutics. No guarantees here but I like how it’s lining up. $LNTH $CATX $INMB
1 · Reply
TI7812
TI7812 Sep. 9 at 8:28 PM
$LNTH Double bottom on the chart and Morgan Stanley before market opened morning presentation combining to put in a bottom for this year? Certainly looks like there were no negative surprises (fingers crossed) at the Morgan Stanley 23rd Annual Global Healthcare Conference, else the stock would not have closed so well in the last 30 minutes.
2 · Reply
Blizzzard
Blizzzard Sep. 9 at 7:55 PM
$LNTH amazing close!!!
0 · Reply
Live2ride
Live2ride Sep. 8 at 8:12 PM
$LNTH We need some volume to come in and push this back above $60. Starting to feel like dead money.
0 · Reply
carepolice
carepolice Sep. 3 at 6:42 PM
$LNTH started position here again. Triple 5 - thats my avg
1 · Reply
RadioIsotope25
RadioIsotope25 Sep. 2 at 11:48 PM
$RADX https://www.biospace.com/fda/fdas-new-radiopharma-guidance-a-greenlight-for-an-accelerating-space $LNTH $CATX $MNPR
1 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 2 at 8:13 AM
$LNTH FDA Accepts Lantheus Holdings, Inc. (LNTH)' NDA for New PSMA Imaging Agent By Laiba Immad | September 02, 2025, 4:05 AM
0 · Reply
maxD2016
maxD2016 Aug. 31 at 7:34 PM
0 · Reply